Topical ET-02 demonstrated successful results in its first-in-human clinical trial for the treatment of androgenic alopecia, Eirion Therapeutics announced in a press release. “Right now, 80 million ...

The global Alopecia Treatment Market is poised for significant growth, with the market estimated to be valued at USD 12.5 billion in 2025 and forecasted to reach USD 30.5 billion by 2035, reflecting a ...

DNA, 2-deoxy-D-ribose molecules link together through phosphate groups to form a sugar-phosphate backbone. This backbone ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.

You might experience seasonal hair loss at certain times of the year. Seasonal changes can affect the hair growth cycle, ...

Results from Amplifica’s first in-human trial show promise for a new potential hair loss treatment. The trial evaluated the ...

Topical Gel pre-IND meeting and on track to begin Phase 2a clinical trial in alopecia areata in Q2 2025 Unaudited cash and cash equivalents of approximately $70 million as of December 31, 2024 WARREN, ...

A new hair regrowth gel could soon see the light of day, giving us new ways to treat permanent baldness in both men and women ...

When it comes to the efficacy of a hair loss treatment, there’s nothing more telling than a before and after photo.

Alopecia areata (AA) is a common autoimmune disease that leads to sudden circular hair loss. The clinical course of AA is ...

It's common for a person to notice signs of hair loss as they age. However, for many people, losing their hair is akin to ...

Low-dose oral minoxidil, the hair growth drug which is the active ingredient in Rogaine, may be safe and effective for ...